COST-Q 6 COST-Q 6 LLY-N 14.5 C-N 1.22 GM-N 1.12 SNEX-Q 6.32 RIO-N -0.28 AOMR-N 0.02 AGIO-Q 0.48 AC-T -0.15
Home Daily Stock Opinions and Ratings King Pharmaceuticals (KG-N)

King Pharmaceuticals (KG-N)

NEW AI Investor Insights
0 watching

0.00
0.00 (0.00%) 1d
0
BUY

King Pharmaceuticals(KG-N)

Apr 30, 2004
A potential takeover play. Has been a bit undermanaged and is very cheap.
David King
Unknown
Unlock Rating
$17.250

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

King Pharmaceuticals(KG-N)

Dec 19, 2003
Technical support is $12.75. A lot of upside potential. Fair market value is $35/40. However, earnings forecast trend is in a decline.
Ross Healy
Unknown
Unlock Rating
$14.680

Stock price when the opinion was issued

biotechnology pharmaceutical
PAST TOP PICK

King Pharmaceuticals(KG-N)

Sep 25, 2003
(A top pick Aug 12/03. Up 3%.) Still likes. An outstanding value for investors to focus on.
Brian Acker, CA
Owned
Unlock Rating
$15.250

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Sep 15, 2003
Has great value. US Healthcare looks very inexpensive.
Brian Acker, CA
Owned
Unlock Rating
$16.120

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Sep 03, 2003
Will be volatile. An OK company at a bargain price. Good risk/reward.
Peter Arender, CFA
Owned
Unlock Rating
$14.200

Stock price when the opinion was issued

biotechnology pharmaceutical
WEAK BUY

King Pharmaceuticals(KG-N)

Aug 22, 2003
Generic drug makers have been on quite a role.A good group to have exposure to.This company has FCC and business model problems.Risky.
Matt Barasch
Unknown
Unlock Rating
$13.970

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Aug 12, 2003
(Was a top pick on July 14, 2003.Up 15%.)Still likes.Good earnings. Came out with a relatively good performance report.Got hit by a sudden move of defense money moving into cyclical areas.Got too cheap.
Brian Acker, CA
Owned
Unlock Rating
$13.920

Stock price when the opinion was issued

biotechnology pharmaceutical
TOP PICK

King Pharmaceuticals(KG-N)

Jul 14, 2003
Systems indicate a top pick. Cheap and has earnings.
Brian Acker, CA
Unknown
Unlock Rating
$16.250

Stock price when the opinion was issued

biotechnology pharmaceutical
DON'T BUY

King Pharmaceuticals(KG-N)

Nov 07, 2002
Fundamentally should be good, but the stock languishes.
Brian Acker, CA
Unknown
Unlock Rating
$15.910

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

King Pharmaceuticals(KG-N)

Aug 16, 2002
Cheap/ Good growth prospects. Only own a small portion in your portfolio.
Robert Floyd
Unknown
Unlock Rating
$19.380

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 10 of 10 entries
  • «
  • ‹
  • 1
  • ›
  • »

King Pharmaceuticals(KG-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for King Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

King Pharmaceuticals(KG-N) Frequently Asked Questions

What is King Pharmaceuticals stock symbol?

King Pharmaceuticals is a OTC stock, trading under the symbol KG-N on the (). It is usually referred to as or KG-N

Is King Pharmaceuticals a buy or a sell?

In the last year, there was no coverage of King Pharmaceuticals published on Stockchase.

Is King Pharmaceuticals a good investment or a top pick?

King Pharmaceuticals was recommended as a Top Pick by on . Read the latest stock experts ratings for King Pharmaceuticals.

Why is King Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is King Pharmaceuticals worth watching?

In the last year 0 stock analysts on Stockchase covered King Pharmaceuticals. The stock is worth watching.

What is King Pharmaceuticals stock price?

On , King Pharmaceuticals (KG-N) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Latest Buy Signals

CRM-NSalesForce.com Inc.
SalesForce.com Inc.
$279.39
0.66 (0.24%)
MLM-NMartin Marietta Materials
Martin Marietta Materials
$490.20
2.01 (0.41%)
VMC-NVulcan Materials Co.
Vulcan Materials Co.
$241.11
4.61 (1.88%)
SLB-NSchlumberger Ltd.
Schlumberger Ltd.
$41.08
-0.05 (-0.12%)
MS-NMorgan Stanley
Morgan Stanley
$119.85
1.74 (1.43%)
Advertising

Today's Top Picks

LLY-NEli Lilly & Co.
Eli Lilly & Co.
$837.01
14.50 (1.70%)
COST-QCostco Wholesale Corporation
Costco Wholesale Corporation
$904.05
6.00 (0.66%)
COST-QCostco Wholesale Corporation
Costco Wholesale Corporation
$904.05
6.00 (0.66%)
META-QMeta Platforms, Inc.
Meta Platforms, Inc.
$584.06
1.70 (0.29%)
AGIO-QAgios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
$31.68
0.48 (1.49%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

APA-NApache Corp
Apache Corp
$20.81
0.64 (2.98%)
COST-QCostco Wholesale Corporation
Costco Wholesale Corporation
$904.05
6.00 (0.66%)
F-NFord Motor
Ford Motor
$10.17
0.22 (2.12%)
DHR-NDanaher Corp.
Danaher Corp.
$210.26
-2.52 (-1.21%)
NVDA-QNVIDIA Corporation
NVIDIA Corporation
$117.52
2.09 (1.75%)

Most Recent Experts

Weiss

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Lebenthal

Jim Lebenthal

Cerity Partners

Sethi

Sarat Sethi, Managing Partner, Douglas C. Lane & Assoc.

Douglas C. Lane & Assoc.

Gardner

Brianne Gardner

Raymond James

Reid

Gordon Reid

GoodReid Investment Counsel

Advertising
Advertising
© Stockchase Inc.